Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36cc698e-5fbd-4077-a423-286c318da9aa&Preview=1 -
Date
11/27/2012 -
Company Name
Rhythm Pharmaceuticals -
Mailing Address
855 Boylston Street, 11th Floor Boston, MA 02116 -
Company Description
Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. -
Website
http://www.rhythmtx.com -
Transaction Type
Venture Equity -
Transaction Amount
$8,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Rhythm will use the proceeds to further develop its small-peptide therapeutics for metabolic diseases. -
M&A Terms
-
Venture Investor
Pfizer Venture Investments
